Sort
21,453 grants matching “tuberculosis”
Virginia Department of Health, Tuberculosis Elimination and Laboratory Cooperative Agreement
$1,601,629Jane Moore · Virginia State Dept Of Health · U52 · FY2015 · PS
Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa
$1,599,493Larry William Chang · Johns Hopkins University · R01 · FY2022 · HL
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU
$1,598,938University Of Puerto Rico Med Sciences · U01 · FY2003 · AI
CENTER FOR AIDS RESEARCH(CFAR)
$1,598,632Michael Marcel Lederman · Case Western Reserve University · P30 · FY2007 · AI
15 Tesla Bruker SolariX FT-ICR mass spectrometer
$1,596,640Richard M Caprioli · Vanderbilt University · S10 · FY2012 · OD
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$1,594,015Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$1,591,967Catherine C McGowan · Vanderbilt University · U01 · FY2012 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,591,480University Of Washington · U01 · FY2004 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,591,323Richard Stancil · Houston Department/Health/Human Srvs · U52 · FY2015 · PS
Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda
$1,588,271Charles Martyn Bark · Case Western Reserve University · R01 · FY2019 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,588,110University Of Pittsburgh At Pittsburgh · U01 · FY2004 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,583,919Lesia D Woods · Tennessee State Department Of Health · U52 · FY2006 · PS
Comparative Biomedical Scientist Training Program
$1,583,589Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2019 · CA
Exploring the impact of inflammaging on immune function during M. tb infection
$1,582,677Joanne Turner · Ohio State University · P01 · FY2017 · AG
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,582,517Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2014 · AI
Viable but Nonculturable Mtb
$1,581,787Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2015 · AI
Molecular Analysis of Tuberculosis Immunity
$1,580,467William Robert Jacobs · Albert Einstein College Of Medicine, Inc · P01 · FY2015 · AI
Genes And Gene Products As Immunoadjuvants
$1,580,416Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,579,393Sue Etkind · Ma St Executive Office Of Health & Human Services · U52 · FY2007 · PS
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
$1,578,677Jeanette Coffin · Midwest Research Institute · N01 · FY2023 · AI
Development of simple formulations for vaccine use
$1,577,096Arya Biragyn · National Institute On Aging · ZIA · FY2020 · AG
Human immune signatures of latent MTB infection, active disease and BCG vaccination
$1,576,438Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2017 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$1,573,205Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,572,218University Of Southern California · U01 · FY2001 · AI
Development of Gleevec for TB and TB/HIV
$1,571,205Daniel Kalman · Emory University · UH3 · FY2019 · AI